Kroger Specialty Pharmacy is proud to announce it is now dispensing ALECENSA, GAVRETO, and ROZLYTREK to expand our extensive list of specialty medications in Oncology.
ALECENSA is a prescription medicine used to treat people with non-small cell lung cancer that has spread to other parts of the body (mNSCLC) and is caused by an abnormal anaplastic lymphoma kinase (ALK) gene.
GAVRETO (pralsetinib) is a prescription medicine used to treat certain cancers caused by abnormal rearranged during transfection (RET) gene in:
ROZLYTREK is a prescription medicine used to treat:
Jeremy Richardson, Vice President of Sales for Kroger Specialty Pharmacy, shared his thoughts on the news of dispensing ALECENSA, GAVRETO, and ROZLYTREK for Genentech. “Creating partnerships to assist in the treatment and care of the most vulnerable patient populations is exactly why Kroger Specialty Pharmacy exists. With a mission to provide a high-touch, caring experience for patients undergoing complex chronic medication therapy, our clinical oncology care team understands the complexities of a cancer diagnosis and has the unique ability to guide patients and their caregivers through the healthcare journey. Incorporating these specialty medications will expand our already extensive oncology presence to ensure more patients, caregivers, and providers can experience the highest level of care.”
Frank Scimeca, PharmD, MBA, BCOP, Director – Clinical Operations, for Kroger Specialty Pharmacy, explains the positive impact ALECENSA, GAVRETO, and ROZLYTREK brings to our Oncology LDD portfolio. “As the largest independent specialty pharmacy, we have the ability to create customized clinical programs for our pharma partners. Genentech's products; ALECENSA, GAVRETO, and ROZLYTREK are a perfect match for our services as we have the ability to identify the clinical care path that best supports the patients journey to ensure they remain on therapy. Our extensive knowledge within Oncology paired with our proprietary Oncology Dashboard, enables us to partner with Genentech in a way that delivers meaningful, real-time data to ensure patients remain on therapy and experience the best clinical outcomes. The landscape of care is changing, and our ability to pivot for the patient’s best interests is a core differentiator.”
At Kroger Specialty Pharmacy our clinical and care teams have extensive experience with the treatment challenges that can arise when dealing with Oncology. We are passionate about simplifying the enrollment process for our patients by providing comprehensive financial services and personalized patient care support.
About Kroger Specialty Pharmacy:
At Kroger Specialty Pharmacy, our mission is to be the preferred pharmacy for people undergoing complex medication therapies by optimizing clinical outcomes and providing a high-touch, caring experience. As the largest independent specialty pharmacy by provider choice, Kroger Specialty Pharmacy offers comprehensive therapy-management programs as well as injectable and oral pharmaceutical treatments for Oncology – as well as Dermatology, HIV, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Growth Hormone Deficiency, Hunters Syndrome, Hemophilia, IVIG, HAE plus others. Kroger Specialty Pharmacy services patients in all 50 states and Puerto Rico and is ACHC and URAC Accredited in numerous sites. Kroger Specialty Pharmacy's clinically effective and cost-efficient therapy management programs provide direct value to healthcare organizations nationwide. We blend a high-touch, caring patient experience with specialized clinical knowledge, personalized care programs, and administrative expertise. For more information, visit www.krogerspecialtypharmacy.com.
About Genetech Healthcare:
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit www.gene.com.www.gene.com.
Trade marks are owned by or licensed to Genentech, Inc. a member of the Roche Group. ©2023 Genentech, Inc.